Table 1.
Sociodemographic characteristics and association between presence of HPV and risk factors of participants at basal sampling and 12 months after HPV detection
| Variable | Young adults | Middle-aged adults | Young and middle-aged adults | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Time at sampling | Time zero | Time zero | 12 months later | ||||||||
| n | 85 | 9 | 19 | ||||||||
| Age range | 18–35 | 36–55 | 20–49 | ||||||||
| Mean age (SD) | 21.68 (3.35) | 43.11 (5.64) | 25.84 (9.88) | ||||||||
| Sociodemographic characteristics | HPV infection | p | Sociodemographic characteristics | HPV infection | p | HPV infection | p | ||||
| Pre | Abs | Pre | Abs | Pre | Abs | ||||||
| Sex n (%) | |||||||||||
|
Male Female |
37 (43.52) 48 (56.47) |
21 (24.70) 20 (23.52) |
16 (18.82) 28 (32.94) |
0.19 |
4 (44.44) 5 (55.55) |
1 (11.11) 2 (22.22) |
3 (33.33) 3 (33.33) |
> 0.99 |
9 (47.36) 1 (5.26) |
7 (36.84) 2 (10.52) |
0.58 |
| Tobacco consumption n (%) | |||||||||||
|
Light Moderate/heavy |
85 (100) 0 |
41 (48.23) 0 |
44 (51.76) 0 |
> 0.99 |
8 (88.88) 1 (11.11) |
2 (22.22) 1 (11.11) |
6 (66.66) 0 |
0.33 |
5 (26.31) 5 (26.31) |
5 (26.31) 3 (3.52) |
0.64 |
| Alcohol consumption n (%) | |||||||||||
|
Low risk Hazardous/harmful |
59 (69.41) 26 (30.58) |
29 (34.11) 12 (14.11) |
30 (35.29) 14 (16.47) |
0.79 |
7 (77.77) 2 (22.22) |
2 (22.22) 1 (11.11) |
5 (55.55) 1 (11.11) |
> 0.99 |
10 (52.63) 0 |
8 (42.10) 1 (5.26) |
> 0.99 |
| Age at sexual debut n (%) | |||||||||||
|
12–15 16–20 21 onwards |
7 (8.23) 73 (85.88) 5 (5.88) |
3 (3.52) 38 (44.70) 0 |
4 (4.70) 35 (41.17) 5 (5.88) |
0.07 |
0 6 (66.66) 3 (33.33) |
0 2 (22.22) 1 (11.11) |
0 4 (44.44) 2 (22.22) |
– |
6 (31.57) 7 (36.84) |
6 (31.57) 0 |
0.043 |
| Lifetime number of sexual partners n (%) | |||||||||||
|
1–2 3 or more |
39 (45.88) 46 (54.11) |
18 (21.17) 23 (27.05) |
21 (24.70) 23 (27.05) |
0.82 |
7 (77.77) 2 (22.22) |
3 (33.33) 0 |
4 (44.44) 2 |
0.50 |
2 (10.52) 8 (42.10) |
5 (26.31) 4 (21.05) |
0.16 |
| Oral sex practice n (%) | |||||||||||
|
Yes No |
67 (78.82) 18 (21.17) |
30 (35.29) 11 (12.94) |
37 (43.52) 7 (8.23) |
0.29 |
5 (55.55) 4 (44.44) |
2 (22.22) 1 (11.11) |
3 (33.33) 3 (33.33) |
> 0.99 |
9 (47.36) 1 (5.26) |
5 (26.31) 4 (21.05) |
0.14 |
| Condom use n (%) | |||||||||||
|
Yes No |
50 (58.82) 35 (41.17) |
18 (21.17) 23 (27.05) |
32 (37.64) 12 (14.11) |
0.007 |
3 (33.33) 6 (66.66) |
1 (11.11) 2 (22.22) |
1 (11.11) 5 (55.55) |
> 0.99 |
5 (26.31) 5 (26.31) |
4 (21.05) 5 (26.31) |
> 0.99 |
| Vaccinated n (%) | |||||||||||
|
Yes No |
8 (9.41) 77 (90.58) |
4 (4.70) 37 (43.52) |
4 (4.70) 40 (47.05) |
> 0.99 |
0 9 (100) |
0 3 (33.33) |
0 6 (66.66) |
> 0.99 |
1 (5.26) 9 (47.36) |
2 (10.52) 7 (36.84) |
0.58 |
Bold numbers indicate a statistically significant value
HPV infection human papillomavirus infection; Pre present; Abs absent